[Form 4] Rise Gold Corp. Insider Trading Activity

Rhea-AI Filing Summary

Rise Gold Corp. (RYES) director Lawrence W. Lepard filed a Form 4 reporting his equity holdings and a new option grant. On 11/20/2025, he received options to purchase 150,000 shares of common stock at an exercise price of $0.18 per share, exercisable on that same date and expiring on 11/20/2030. After this transaction, he holds common shares directly and also indirectly through EMA GARP FUND LP, Sea View Investments, LLC, and for the benefit of his children. He also reports multiple previously granted options and warrants with exercise prices ranging from $0.10 to $0.65 and expirations between 2027 and 2030, highlighting his ongoing equity-linked exposure to the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lepard Lawrence Ward

(Last) (First) (Middle)

59 NORTH MAIN STREET #1

(Street)

SHERBORN MA 01770

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rise Gold Corp. [ RYES ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								977,405	D
Common Stock								2,559,656	I	By EMA GARP FUND LP
Common Stock								904,000	I	By Sea View Investments, LLC
Common Stock								135,000	I	By Lepard children

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$0.18	11/20/2025		A		150,000		11/20/2025	11/20/2030	Common Stock	150,000	$0.00	150,000	D
Options	$0.25							10/30/2025	10/30/2030	Common Stock	100,000		100,000	D
Options	$0.1							05/22/2025	05/22/2030	Common Stock	60,000		60,000	D
Options	$0.1							03/25/2025	03/25/2030	Common Stock	60,000		60,000	D
Options	$0.17							05/01/2024	05/01/2029	Common Stock	15,000		15,000	D
Options	$0.25							12/12/2023	12/12/2028	Common Stock	47,775		47,775	D
Options	$0.53							02/21/2023	02/21/2028	Common Stock	105,000		105,000	D
Options	$0.65							02/07/2022	02/07/2027	Common Stock	100,000		100,000	D
Warrants	$0.158							04/29/2024	04/29/2027	Common Stock	105,265		105,265	D

Explanation of Responses:

	/s/ Lawrence W. Lepard	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Rise Gold Corp. (RYES) report in this Form 4 filing?

This Form 4 shows that director Lawrence W. Lepard reported a new stock option grant and detailed his direct and indirect holdings of Rise Gold Corp. common stock and derivatives.

How many new Rise Gold (RYES) options were granted to Lawrence W. Lepard?

Lawrence W. Lepard received 150,000 stock options on 11/20/2025, each giving the right to buy one share of Rise Gold Corp. common stock.

What is the exercise price and term of the new RYES stock options?

The new options have an exercise price of $0.18 per share, became exercisable on 11/20/2025, and are scheduled to expire on 11/20/2030.

What indirect Rise Gold (RYES) holdings does Lawrence W. Lepard report?

He reports indirect ownership of Rise Gold Corp. common stock through EMA GARP FUND LP, Sea View Investments, LLC, and for the benefit of his Lepard children.

What other derivative securities linked to RYES does Lawrence W. Lepard hold?

He holds several existing options and warrants on Rise Gold Corp. common stock, with exercise prices from $0.10 to $0.65 and expirations between 2027 and 2030.

What is the reporting person’s relationship to Rise Gold Corp. (RYES)?

Lawrence W. Lepard is identified as a director of Rise Gold Corp. in this Form 4 filing.